Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.13B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 3 |
Apple
AAPL
|
+$836M |
| 4 |
Alibaba
BABA
|
+$807M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$429M |
| 2 |
Boeing
BA
|
+$402M |
| 3 |
Coty
COTY
|
+$284M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$104M |
| 5 |
Qualcomm
QCOM
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.12% |
| 2 | Technology | 2.44% |
| 3 | Consumer Discretionary | 1.83% |
| 4 | Communication Services | 1.72% |
| 5 | Financials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
ProShares Ultra Dow30
DDM
$585M
| $3.92M | ﹤0.01% |
161,800
-12,800
| -7% | -$300K |
|
3027
CALL
Entergy
ETR
$49.3B
| $3.92M | ﹤0.01% |
76,200
-537,000
| -88% | -$26.2M |
|
|
STAY
3028
CALL
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $3.92M | ﹤0.01% |
232,000
+136,700
| +143% | +$2.41M |
|
|
CEO
3029
CALL
DELISTED
CNOOC Limited
CEO
| $3.92M | ﹤0.01% |
23,000
-33,300
| -59% | -$5.8M |
|
3030
CALL
W.P. Carey
WPC
$16.1B
| $3.91M | ﹤0.01% |
49,212
-42,168
| -46% | -$3.34M |
|
3031
Vanguard Morningstar Value ETF
VTV
$192B
| $3.91M | ﹤0.01% |
+35,269
| New | +$3.85M |
|
3032
CALL
Bio-Rad Laboratories Class A
BIO
$10.4B
| $3.91M | ﹤0.01% |
12,500
-135,700
| -92% | -$40.6M |
|
3033
PUT
Kinross Gold
KGC
$37.1B
| $3.9M | ﹤0.01% |
1,005,900
-195,500
| -16% | -$659K |
|
|
HEES
3034
CALL
DELISTED
H&E Equipment Services
HEES
| $3.9M | ﹤0.01% |
133,900
+13,000
| +11% | +$362K |
|
3035
PUT
United Therapeutics
UTHR
$22.1B
| $3.9M | ﹤0.01% |
49,900
+3,800
| +8% | +$355K |
|
3036
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$347M
| $3.89M | ﹤0.01% |
2,116
+948
| +81% | +$1.87M |
|
|
EVBG
3037
CALL
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3.89M | ﹤0.01% |
43,500
+30,900
| +245% | +$2.44M |
|
3038
PUT
Trupanion
TRUP
$1.3B
| $3.89M | ﹤0.01% |
107,600
+28,700
| +36% | +$943K |
|
|
RETA
3039
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.89M | ﹤0.01% |
41,200
-36,200
| -47% | -$3.13M |
|
3040
CALL
Insmed
INSM
$25.9B
| $3.89M | ﹤0.01% |
151,800
-145,100
| -49% | -$4.04M |
|
3041
CALL
Workiva
WK
$4.31B
| $3.89M | ﹤0.01% |
66,900
+21,000
| +46% | +$1.13M |
|
3042
PUT
Synaptics
SYNA
$3.72B
| $3.88M | ﹤0.01% |
133,100
-233,200
| -64% | -$7.61M |
|
|
3043
PUT
Bio-Rad Laboratories Class A
BIO
$10.4B
| $3.88M | ﹤0.01% |
12,400
-8,500
| -41% | -$2.55M |
|
|
AVP
3044
DELISTED
Avon Products, Inc.
AVP
| $3.87M | ﹤0.01% |
998,089
-25,848
| -3% | -$86.1K |
|
3045
CALL
The Greenbrier Companies
GBX
$1.42B
| $3.87M | ﹤0.01% |
127,300
+50,100
| +65% | +$1.59M |
|
|
MDSO
3046
PUT
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.87M | ﹤0.01% |
42,700
+24,500
| +135% | +$2.15M |
|
|
BREW
3047
DELISTED
Craft Brew Alliance, Inc.
BREW
| $3.86M | ﹤0.01% |
276,183
+21,671
| +9% | +$310K |
|
3048
PUT
Leggett & Platt
LEG
| $3.86M | ﹤0.01% |
100,600
+57,500
| +133% | +$2.27M |
|
|
ANAT
3049
CALL
DELISTED
American National Group, Inc. Common Stock
ANAT
| $3.85M | ﹤0.01% |
33,100
+18,200
| +122% | +$2.11M |
|
|
CLVS
3050
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.85M | ﹤0.01% |
259,100
-33,300
| -11% | -$602K |
|
Similar funds
Jeff Yass's Q2 2019 Portfolio in Review
As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $17.9B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.
- Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
- Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
- Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
- Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
- Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
- Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.